Does Zyn Cause Cancer? What FDA, NCI and Studies Show
Does Zyn Cause Cancer? What FDA, NCI and Studies Show
There is no evidence yet that ZYN causes cancer, and no evidence that it doesn't. No long-term study of nicotine pouch users and cancer outcomes exists as of October 2026. ZYN contains no tobacco leaf, and lab tests find nitrosamines, the main cancer-causing chemicals in dip and chew, absent or at trace levels. FDA says ZYN poses a lower cancer risk than cigarettes. That is not the same as safe.
On June 30, 2026, FDA authorized 20 ZYN products to carry a claim that using ZYN instead of cigarettes lowers the risk of mouth cancer, lung cancer, and four other conditions. The word "cancer" in a ZYN marketing sentence triggered a wave of questions. Below: what federal agencies, labs, and published studies have found, and where the evidence stops.
What Causes Cancer in Smokeless Tobacco?
Smokeless tobacco (dip, chewing tobacco, moist snuff) causes oral cancer, esophageal cancer, and pancreatic cancer, according to the National Cancer Institute. The NCI identifies at least 28 cancer-causing chemicals in smokeless tobacco, with tobacco-specific nitrosamines (TSNAs) as the most harmful. Polonium-210 and polycyclic aromatic hydrocarbons (PAHs) are also on the list.
ZYN's published ingredient list includes nicotine salt, hydroxypropyl cellulose, microcrystalline cellulose (MCC), maltitol, gum arabic, sodium carbonate/bicarbonate, sweeteners, and flavorings. No tobacco leaf. The nitrosamines NCI ranks as most harmful are tobacco-specific, so the question is whether removing the leaf removes the risk. Lab data starts to answer that. Long-term human data does not yet exist.
Does ZYN Contain Nitrosamines?
Two studies looked at the chemistry of nicotine pouches. Their findings overlap but are not identical, and their funding matters.
Back et al., BMC Chemistry 2023 (PubMed): All four authors were employees of or funded by Swedish Match AB, ZYN's maker. They screened 43 compounds in ZYN dry and moist products, General snus, two moist snuff products, Nicorette lozenge, and Nicotinell gum. The two ZYN products contained no quantifiable nitrosamines or PAHs but showed low levels of ammonia, chromium, formaldehyde, and nickel. The count of quantified harmful constituents in ZYN was similar to the two nicotine-replacement products.
Mallock et al., Tobacco Control 2024 (PubMed): Researchers at Germany's Federal Institute for Risk Assessment (BfR), no competing interests declared, tested 44 nicotine pouches from 20 manufacturers. TSNAs were detected in 26 of 44 products, with a maximum of 13 ng NNN per pouch. The abstract does not name which brands tested positive.
| Study | Lab / funding | Products tested | Nitrosamines found? |
|---|---|---|---|
| Back et al. 2023 | Swedish Match (ZYN's maker) | 2 ZYN products + comparators | None quantified in ZYN |
| Mallock et al. 2024 | BfR (German government), no competing interests | 44 pouches, 20 makers | Detected in 26 of 44; max 13 ng NNN per pouch |
Source: PubMed abstracts, checked Oct 2026.
Even in the government-run BfR study, the highest nitrosamine level was measured in nanograms per pouch. Whether trace exposure over decades matters is the open question; nobody has studied that in pouch users yet.
What We Know and Don't Know, by Cancer Type
| Cancer type | Smokeless tobacco (dip, chew) | Swedish snus (nearest long-term proxy) | ZYN / nicotine pouches |
|---|---|---|---|
| Mouth (oral) | Causes it (NCI) | No association in 418,369 men (HR 0.90, 95% CI 0.74 to 1.09) | No outcome data; white lesions at pouch site in a 5-person case series |
| Esophagus | Causes it (NCI) | Not covered in sources here | No outcome data |
| Pancreas | Causes it (NCI) | No association in 424,152 men (HR 0.96, 95% CI 0.83 to 1.11) | No outcome data |
| All cancer deaths | Not stated by NCI page | Slightly higher in never-smoking men who used snus (aHR 1.12, 95% CI 1.00 to 1.26) | No outcome data |
Sources: NCI smokeless tobacco fact sheet; Swedish Collaboration on Health Effects of Snus Use pooled cohorts, men only (Araghi 2021, Araghi 2017, Byhamre 2021); PubMed checked Oct 17, 2026. Snus contains tobacco; ZYN does not.
Evidence column = the strongest primary source found per row, with a PubMed search run on Oct 17, 2026 confirming no cancer-outcome study of nicotine pouch users has been published.
Does ZYN Cause Mouth or Gum Cancer?
No study has linked ZYN, or any nicotine pouch, to oral cancer. A Latvian case series of five pouch users found white mucosal lesions at the placement site (Miluna-Meldere et al., Diagnostic Pathology 2024). Histology showed parakeratosis, oedema, and chronic inflammation. Those are tissue changes, not cancer, and the study is tiny.
The nearest long-term proxy is Swedish snus, which is tobacco-based and carries higher carcinogen levels than pouches. In a pooled analysis of 418,369 Swedish men, ever snus use versus never use showed an adjusted HR of 0.90 (95% CI 0.74 to 1.09) for oral cancer (Araghi et al., 2021), meaning no association was found. Among never smokers the HR was 0.87 (0.57 to 1.32). The caveat: snus is not ZYN, the cohort was all male, and snus has more carcinogens than a tobacco-free pouch.
For more on what pouches do to gum tissue, see our ZYN and gum health review.
What FDA Did and Did Not Say About ZYN and Cancer
FDA has issued two separate orders for ZYN. Both compare ZYN to cigarettes and most smokeless tobacco. Neither calls ZYN safe.
| FDA action | Date | What it said | What it did not say |
|---|---|---|---|
| PMTA marketing order (source) | Jan 16, 2025 | ZYN products "pose lower risk of cancer and other serious health conditions" than cigarettes and most smokeless tobacco | "It does not mean these tobacco products are safe, nor are they 'FDA approved.'" |
| MRTP modified-risk order (source) | Jun 30, 2026 | Authorized claim: "Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis." | "There is no safe tobacco product, and those who do not use tobacco products should not start." Orders expire in 5 years; postmarket surveillance required. |
Source: FDA.gov, checked Oct 2026.
"Authorized" means FDA permitted a specific marketing claim. It does not mean the agency declared ZYN non-carcinogenic or recommended it. FDA noted it may withdraw the order if it sees a significant increase in youth uptake.
Is Nicotine Itself a Carcinogen?
FDA separates the two: the thousands of chemicals in tobacco and tobacco smoke, not nicotine, are what FDA identifies as the cause of tobacco's serious health effects, including cancer. That framing matters but has limits. It tells you what causes tobacco's cancer burden, not that nicotine is harmless.
Nicotine is addictive (NCI). FDA does not list nicotine as the driver of tobacco-related cancer; that is not the same as proof nicotine carries zero long-term risk on its own.
When to Get a Mouth Spot Checked
See a dentist or doctor if you notice a white or red patch, sore, or lump in your mouth that does not heal. This applies whether you use nicotine pouches, dip, or nothing at all.
If you are pregnant, talk to a clinician about any nicotine use. Nicotine products are 21+ in the US, the federal minimum age for any tobacco product, including nicotine from any source. If you have never used tobacco or nicotine, FDA's position is simple: do not start.
Free quit support: 1-800-QUIT-NOW. See also how to quit ZYN nicotine pouches.
Related from Roon
- Side effects of ZYN pouches
- ZYN vs chewing tobacco: carcinogen data
- ZYN vs cigarettes: how much safer?
Frequently Asked Questions
Do ZYNs cause cancer if you use them every day?
No study has measured cancer rates in daily ZYN users or daily users of any nicotine pouch. The products have not been on the market long enough for the multi-decade cohort research that established the link between dip and oral cancer. Frequency-specific cancer data does not exist for this category.
Is ZYN safer than dip for cancer risk?
ZYN contains lower measured levels of known carcinogens than dip or chewing tobacco. FDA's January 2025 PMTA order stated that ZYN products "pose lower risk of cancer" than cigarettes and most smokeless tobacco. "Lower risk" is the claim, not "no risk." See ZYN vs chewing tobacco carcinogen data for a deeper comparison.
Does ZYN contain formaldehyde?
The Swedish Match-funded study (Back et al., 2023) detected low levels of formaldehyde in both ZYN dry and ZYN moist products. The abstract gives no amounts, and formaldehyde is not on its list for the two nicotine-replacement products tested. All authors were employed or funded by ZYN's maker, which is worth weighing.
Do caffeine pouches cause gum or mouth cancer?
No study has examined caffeine pouches and cancer. IARC classifies caffeine as Group 3: not classifiable as to its carcinogenicity to humans, based on inadequate evidence in both humans and animals. Any oral pouch can cause local tissue irritation at the placement site. For more, see caffeine pouch side effects.
Does quitting ZYN lower your cancer risk?
No pouch-specific data answers that. FDA says fully quitting all tobacco products would most benefit a user's health. Free support: 1-800-QUIT-NOW.
A Pouch With No Tobacco and No Nicotine
The cancer question around ZYN centers on nicotine, nitrosamines, and decades of unknowns. If you're ready to quit nicotine pouches without losing the habit that works for you, try Roon.
Each Roon pouch skips tobacco and nicotine entirely and carries 80 mg caffeine with 60 mg L-theanine, 25 mg methylliberine (Dynamine) and 5 mg theacrine (TeaCrine). Most people feel one pouch for somewhere between 6 and 8 hours, with no jitters and no crash. Methylliberine slows caffeine clearance; a randomized, double-blind crossover PK study (n=12) found co-administration extended caffeine's half-life from 7.2 to 15 hours without raising the peak (study). That study dosed 100 mg methylliberine with 150 mg caffeine, about 4x and 1.9x what one Roon pouch contains, so the mechanism applies directionally, not at the study's exact magnitude. Fifteen hours is a clearance number, not felt duration. Leave at least 8 hours between your last pouch and bedtime.
Roon does not treat nicotine dependence and makes no cancer-risk claim. It is a caffeine pouch, from $9.16 per tin, with a 30-day money-back guarantee on the first order.
Sources
- Smokeless Tobacco and Cancer, NCI (reviewed Oct 25, 2010)
- FDA MRTP orders for ZYN, Jun 30, 2026
- FDA PMTA press release for ZYN, Jan 16, 2025
- FDA: Nicotine Is Why Tobacco Products Are Addictive
- Back et al., BMC Chemistry 2023 (industry-funded: all authors employed by or funded by Swedish Match AB)
- Mallock et al., Tobacco Control 2024 (BfR, no competing interests)
- Miluna-Meldere et al., Diagnostic Pathology 2024
- Araghi et al., Scand J Public Health 2021 (oral cancer)
- Araghi et al., Int J Cancer 2017 (pancreatic cancer)
- Byhamre et al., Int J Epidemiol 2021 (all-cause and cancer mortality)
- IARC Vol. 51, Caffeine evaluation, 1991
Written by Roon Team
